Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4976619 | 0.98 | ALDH1A1 (0.53) | ALDH1A1CYP3A4CA1CA2CA9 | |
| SCHEMBL3838916 | 0.85 | CA2 (0.60) | ALDH1A1CA1CA2CA9 | |
| SCHEMBL3113873 | 0.83 | CA1 (0.54) | ALDH1A1CYP3A4CA1CA2CA9 | |
| SCHEMBL31620700 | 0.83 | CA1 (0.54) | ALDH1A1CYP3A4CA1CA2CA9 | |
| SCHEMBL11672476 | 0.82 | CA2 (0.76) | ALDH1A1CYP3A4CA1CA2CA9 | |
| SCHEMBL10693773 | 0.81 | CYP3A4 (0.56) | ALDH1A1CYP3A4CA1CA2CA9 | |
| SCHEMBL31576122 | 0.80 | ALDH1A1 (0.52) | ALDH1A1CYP3A4CA1CA2CA9 | |
| SCHEMBL8772926 | 0.80 | CA1 (0.50) | ALDH1A1CYP3A4CA1CA2CA9 | |
| SCHEMBL3381331 | 0.80 | ALDH1A1 (0.52) | ALDH1A1CYP3A4CA1CA2CA9 | |
| SCHEMBL31408860 | 0.80 | CA1 (0.50) | ALDH1A1CYP3A4CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9732063-B2 | Kinase inhibitors | RESPIVERT LIMITED (GB) | 2017-08-15 | — | — | US | disclosed |
| EP-2925742-B1 | KINASE INHIBITORS | RESPIVERT LTD (GB) | 2016-10-26 | — | — | EP | disclosed |
| US-20150329523-A1 | KINASE INHIBITORS | OXULAR ACQUISITIONS LIMITED (GB) | 2015-11-19 | — | — | US | disclosed |
| EP-2925742-A1 | KINASE INHIBITORS | Respivert Limited (GB) | 2015-10-07 | — | — | EP | disclosed |
| WO-2014076484-A1 | KINASE INHIBITORS | RESPIVERT LIMITED (GB) | 2014-05-22 | — | — | WO | disclosed |
| CN-102352125-B | Disperse black and blue dye composition | ZHEJIANG RUNTU CO LTD | 2013-08-14 | — | — | CN | disclosed |
| US-8382857-B2 | Method for the reactive coloration of leather | BASF SE (DE) | 2013-02-26 | — | — | US | disclosed |
| US-8382857-B2 | Method for the reactive coloration of leather | BASF SE (DE) | 2013-02-26 | — | — | US | disclosed |
| US-8372161-B2 | Method for the reactive coloring of leather | BASF SE (DE) | 2013-02-12 | — | — | US | disclosed |
| US-8372161-B2 | Method for the reactive coloring of leather | BASF SE (DE) | 2013-02-12 | — | — | US | disclosed |
| EP-1833806-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | AstraZeneca AB (SE) | 2007-09-19 | — | — | EP | disclosed |
| EP-1487824-B1 | DIAMINO-PYRIMIDINES AND THEIR USE AS ANGIOGENESIS INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2007-06-20 | — | — | EP | disclosed |
| EP-1487824-B1 | DIAMINO-PYRIMIDINES AND THEIR USE AS ANGIOGENESIS INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2007-06-20 | — | — | EP | disclosed |
| US-20070033746-A1 | Method for the reactive coloring of leather | BASF AKTIENGESSELLSCHAFT (DE) | 2007-02-15 | — | — | US | disclosed |
| US-20070033746-A1 | Method for the reactive coloring of leather | BASF AKTIENGESSELLSCHAFT (DE) | 2007-02-15 | — | — | US | disclosed |
| WO-2006064189-A1 | OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | disclosed |
| US-20050234083-A1 | Diamino-pyrimidines and their use as angiogenesis inhibitors | SMITHKLINE BEECHAM CORPORATION | 2005-10-20 | — | — | US | disclosed |
| EP-1487824-A1 | DIAMINO-PYRIMIDINES AND THEIR USE AS ANGIOGENESIS INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003074515-A1 | DIAMINO-PYRIMIDINES AND THEIR USE AS ANGIOGENESIS INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2003-09-12 | — | — | WO | disclosed |
| US-4042578-A | POLYESTERS | BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) | 1977-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234083-A1 | Diamino-pyrimidines and their use as angiogenesis inhibitors | TIE1, TEK, KDR | ALDH1A1 994/4885CYP3A4 3874/4885CA1 4846/4885 |
| US-20150329523-A1 | KINASE INHIBITORS | SYK, SRC, BTK | ALDH1A1 4202/4885CYP3A4 2106/4885CA1 4759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.